China Medical System 2026 Interim Net Profit Up 4.77% to RMB986 Million, Revenue RMB4.501 Billion, Interim

China Medical System announced its interim results for the six months ended June 30, 2026. During the period, net profit amounted to RMB986 million, up 4.77% year on year, with earnings per share of 40.75 cents. The board declared an interim dividend of 16.34 cents per share. Revenue reached RMB4.501 billion, representing a 12.46% increase from the same period last year.